WMJ Vol 123 Issue 6: COVID-19 Pandemic-Related Perceived Loneliness as a Potential Risk Factor for Worse Outcomes Among People Who are Pregnant or Postpartum
ABSTRACT
Introduction: People in the perinatal period may be especially susceptible to the effects of social isolation and loneliness. We assessed the COVID-19 pandemic-related impact on loneliness and other outcomes in this population.
Methods: A cross-sectional anonymous survey was completed during August–November, 2020, and January–April, 2021, by people who were pregnant or postpartum in Pennsylvania and Wisconsin, respectively. Wilcoxon rank sum, Fisher exact, or chi-square tests were used to compare mental health, substance use, pregnancy-related and overall health, pandemic’s life impact, and social status metrics between 2 groups of respondents: those who screened positive (“Lonely”) versus negative (“Not Lonely”) for loneliness. Multivariate logistic regression analysis assessed factors associated with Lonely versus Not Lonely status.
Results: Among 613 respondents, 48.8% were categorized as Lonely. Lonely individuals were more likely to be postpartum (P = 0.01); nulliparous (P = 0.04); have more pregnancy complications (P = 0.049); have a diagnosed mood disorder (P < 0.001); receive mental health care (P < 0.001); have elevated depression (P < 0.001), anxiety (P < 0.001), and stress (P < 0.001) scores; rate their social status as lower (P < 0.001); and endorse a worse pandemic-life impact (P < 0.001). A multivariate analysis identified that being postpartum (OR 0.59; 95% CI, 0.40-0.87) and having worse depression (OR 1.24; 95% CI, 1.13-1.36), stress (OR 0.41; 95% CI, 0.28-0.60), perceived social status (OR 0.83; 95% CI, 0.73-0.95), and pandemic-life impact (OR 1.79; 95% CI, 1.11-2.93) were associated with the Lonely status.
Conclusions: Early during the COVID-19 pandemic, screening positive for loneliness was associated with a worse biopsychosocial profile and more pregnancy complications among people in the perinatal period. Focusing efforts on preventing loneliness may help improve outcomes critical for maternal-fetal and child health.
Intended Audience
The intended audience for this continuing education activity is healthcare professionals caring for the people of Wisconsin and beyond.
Learning Objectives
As a result of participating in this journal-based activity, healthcare team members will be able to:
- Discuss the unique impact of the COVID-19 pandemic on people who were pregnant of postpartum.
- Explain the study findings regarding the associations between perceived loneliness, pregnancy complications, and mental health in the perinatal period.
- Develop strategies for healthcare teams to screen for loneliness and mental health problems to improve perinatal health outcomes.
FACULTY DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
| Name of Individual | Individual's Role in Activity | Financial Relationship Disclosure | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices |
| Marianna Shershneva, MD, PhD | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| James Eberhard, MFA | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| Emma C. Allen, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Aleksandra E. Zgierska, MD, PhD | Author | No relevant relationships with ineligible companies to disclose | No |
| Ellen Goldstein, PhD, MFT | Author | No relevant relationships with ineligible companies to disclose | No |
| Robert P. Lennon, MD, JD | Author | No relevant relationships with ineligible companies to disclose | No |
| Arthur Berg, PhD | Author | No relevant relationships with ineligible companies to disclose | No |
| Caitlin J. Regner, MD | Author | No relevant relationships with ineligible companies to disclose | No |
| Jenae M. Neiderhiser, PhD | Author | No relevant relationships with ineligible companies to disclose | No |
| Rina D. Eiden, PhD | Author | No relevant relationships with ineligible companies to disclose | No |
| Danielle S. Downs, PhD | Author | No relevant relationships with ineligible companies to disclose | No |
| Jill D. Denson, PhD, MSW, APSW | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Lee Dresang, MD | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Fahad Aziz, MD | Editor | No relevant relationships with ineligible companies to disclose | No |
| David Dwyer, PhD, RN, NEBC | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Cassie Meffert, PAC, MPH | Reviewer | No relevant relationships with ineligible companies to disclose | No |
| Jennifer Esch, PharmD, MBA, BCPS | Reviewer | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
| Accreditation Logos | Accreditation Statements |
![]() | In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit Designation Statements | |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. | |
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 ANCC contact hour. | |
![]() | American Academy of Physician Assistants (AAPA) The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 10/27/2026. PAs should only claim credit commensurate with the extent of their participation. |
Continuing Education Units The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour. | |
Available Credit
- 1.00 AAPA Category 1 CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Accessibility
If you need anything to participate in this program, please contact [email protected].
Required Hardware/software
Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.

Facebook
X
LinkedIn
Forward
